McClellan, Crawford On "Critical Path" To Secure Congress' Support For Drug Development Project
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA Acting Commissioner Crawford tells FDLI conference that FDA "absolutely must" work with Congress to broaden support for new initiatives. FDA will enlist the help of CMS Administrator McClellan.